Rediscovering Kemp’s Ridley Sea Turtle (<em>Lepidochelys kempii</em>): Molecular Analysis and Threats

Sea turtles are reptiles that have inhabited the earth for 100 million years. These are divided into 2 families (Cheloniidae and Dermochelyidae) and 7 species of sea turtles in the world: the leatherback turtle (Dermochelys coriacea); hawksbill turtle (Eretmochelys imbricata); Kemp’s ridley (Lepidochelys kempii); olive ridley (L. olivacea); Loggerhead turtle (Caretta caretta); flatback sea turtle (Natator depressus) and green turtle (Chelonia mydas). In particular, Kemp’s ridley is included in the red list of IUCN categorized as “critically endangered”. The most important site around the Word is in Rancho Nuevo, Tamaulipas, Mexico. Where 80–95% of the world’s nesting is concentrated. Other nesting areas are Tepeguajes and Barra del Tordo, in Tamaulipas, and with less intensity in Veracruz (Lechuguillas and El Raudal beaches) and South Padre Island, Texas, USA. They deposit an average of about 90 eggs and hatching takes 40 to 60 days. Therefore, they are vulnerable to different anthropogenic activities and sources of pollution, such as heavy metals, which can cause toxic effects that are harmful to the turtles, damage their physiology and health. To understand the real situation about health and genetic parameters it is necessary to analyze biochemical and molecular factors in this species

De novo assembly and transcriptome characterization of the freshwater prawn Palaemonetes argentinus: Implications for a detoxification response

Palaemonetes argentinus, an abundant freshwater prawn species in the northern and central region of Argentina, has been used as a bioindicator of environmental pollutants as it displays a very high sensitivity to pollutants exposure. Despite their extraordinary ecological relevance, a lack of genomic information has hindered a more thorough understanding of the molecular mechanisms potentially involved in detoxification processes of this species. Thus, transcriptomic profiling studies represent a promising approach to overcome the limitations imposed by the lack of extensive genomic resources for P. argentinus, and may improve the understanding of its physiological and molecular response triggered by pollutants. This work represents the first comprehensive transcriptome-based characterization of the non-model species P. argentinus to generate functional genomic annotations and provides valuable resources for future genetic studies. Trinity de novo assembly consisted of 24,738 transcripts with high representation of detoxification (phase I and II), anti-oxidation, osmoregulation pathways and DNA replication and bioenergetics. This crustacean transcriptome provides valuable molecular information about detoxification and biochemical processes that could be applied as biomarkers in further ecotoxicology studies.Instituto de Investigaciones Bioquímicas de La PlataInstituto de Limnología "Dr. Raúl A. Ringuelet

Lancet

BACKGROUND: In 2015, the second cycle of the CONCORD programme established global surveillance of cancer survival as a metric of the effectiveness of health systems and to inform global policy on cancer control. CONCORD-3 updates the worldwide surveillance of cancer survival to 2014. METHODS: CONCORD-3 includes individual records for 37.5 million patients diagnosed with cancer during the 15-year period 2000-14. Data were provided by 322 population-based cancer registries in 71 countries and territories, 47 of which provided data with 100% population coverage. The study includes 18 cancers or groups of cancers: oesophagus, stomach, colon, rectum, liver, pancreas, lung, breast (women), cervix, ovary, prostate, and melanoma of the skin in adults, and brain tumours, leukaemias, and lymphomas in both adults and children. Standardised quality control procedures were applied; errors were rectified by the registry concerned. We estimated 5-year net survival. Estimates were age-standardised with the International Cancer Survival Standard weights. FINDINGS: For most cancers, 5-year net survival remains among the highest in the world in the USA and Canada, in Australia and New Zealand, and in Finland, Iceland, Norway, and Sweden. For many cancers, Denmark is closing the survival gap with the other Nordic countries. Survival trends are generally increasing, even for some of the more lethal cancers: in some countries, survival has increased by up to 5% for cancers of the liver, pancreas, and lung. For women diagnosed during 2010-14, 5-year survival for breast cancer is now 89.5% in Australia and 90.2% in the USA, but international differences remain very wide, with levels as low as 66.1% in India. For gastrointestinal cancers, the highest levels of 5-year survival are seen in southeast Asia: in South Korea for cancers of the stomach (68.9%), colon (71.8%), and rectum (71.1%); in Japan for oesophageal cancer (36.0%); and in Taiwan for liver cancer (27.9%). By contrast, in the same world region, survival is generally lower than elsewhere for melanoma of the skin (59.9% in South Korea, 52.1% in Taiwan, and 49.6% in China), and for both lymphoid malignancies (52.5%, 50.5%, and 38.3%) and myeloid malignancies (45.9%, 33.4%, and 24.8%). For children diagnosed during 2010-14, 5-year survival for acute lymphoblastic leukaemia ranged from 49.8% in Ecuador to 95.2% in Finland. 5-year survival from brain tumours in children is higher than for adults but the global range is very wide (from 28.9% in Brazil to nearly 80% in Sweden and Denmark). INTERPRETATION: The CONCORD programme enables timely comparisons of the overall effectiveness of health systems in providing care for 18 cancers that collectively represent 75% of all cancers diagnosed worldwide every year. It contributes to the evidence base for global policy on cancer control. Since 2017, the Organisation for Economic Co-operation and Development has used findings from the CONCORD programme as the official benchmark of cancer survival, among their indicators of the quality of health care in 48 countries worldwide. Governments must recognise population-based cancer registries as key policy tools that can be used to evaluate both the impact of cancer prevention strategies and the effectiveness of health systems for all patients diagnosed with cancer. FUNDING: American Cancer Society; Centers for Disease Control and Prevention; Swiss Re; Swiss Cancer Research foundation; Swiss Cancer League; Institut National du Cancer; La Ligue Contre le Cancer; Rossy Family Foundation; US National Cancer Institute; and the Susan G Komen Foundation

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3) : analysis of individual data from 258 cancer registries in 61 countries

Background Leukaemias comprise a heterogenous group of haematological malignancies. In CONCORD-3, we analysed data for children (aged 0–14 years) and adults (aged 15–99 years) diagnosed with a haematological malignancy during 2000–14 in 61 countries. Here, we aimed to examine worldwide trends in survival from leukaemia, by age and morphology, in young patients (aged 0–24 years). Methods We analysed data from 258 population-based cancer registries in 61 countries participating in CONCORD-3 that submitted data on patients diagnosed with leukaemia. We grouped patients by age as children (0–14 years), adolescents (15–19 years), and young adults (20–24 years). We categorised leukaemia subtypes according to the International Classification of Childhood Cancer (ICCC-3), updated with International Classification of Diseases for Oncology, third edition (ICD-O-3) codes. We estimated 5-year net survival by age and morphology, with 95% CIs, using the non-parametric Pohar-Perme estimator. To control for background mortality, we used life tables by country or region, single year of age, single calendar year and sex, and, where possible, by race or ethnicity. All-age survival estimates were standardised to the marginal distribution of young people with leukaemia included in the analysis. Findings 164563 young people were included in this analysis: 121328 (73·7%) children, 22963 (14·0%) adolescents, and 20272 (12·3%) young adults. In 2010–14, the most common subtypes were lymphoid leukaemia (28205 [68·2%] patients) and acute myeloid leukaemia (7863 [19·0%] patients). Age-standardised 5-year net survival in children, adolescents, and young adults for all leukaemias combined during 2010–14 varied widely, ranging from 46% in Mexico to more than 85% in Canada, Cyprus, Belgium, Denmark, Finland, and Australia. Individuals with lymphoid leukaemia had better age-standardised survival (from 43% in Ecuador to ≥80% in parts of Europe, North America, Oceania, and Asia) than those with acute myeloid leukaemia (from 32% in Peru to ≥70% in most high-income countries in Europe, North America, and Oceania). Throughout 2000–14, survival from all leukaemias combined remained consistently higher for children than adolescents and young adults, and minimal improvement was seen for adolescents and young adults in most countries. Interpretation This study offers the first worldwide picture of population-based survival from leukaemia in children, adolescents, and young adults. Adolescents and young adults diagnosed with leukaemia continue to have lower survival than children. Trends in survival from leukaemia for adolescents and young adults are important indicators of the quality of cancer management in this age group.peer-reviewe

Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000–2014 (CONCORD-3)

Background: Survival is a key metric of the effectiveness of a health system in managing cancer. We set out to provide a comprehensive examination of worldwide variation and trends in survival from brain tumors in adults, by histology. Methods: We analyzed individual data for adults (15–99 years) diagnosed with a brain tumor (ICD-O-3 topography code C71) during 2000–2014, regardless of tumor behavior. Data underwent a 3-phase quality control as part of CONCORD-3. We estimated net survival for 11 histology groups, using the unbiased nonparametric Pohar Perme estimator. Results: The study included 556,237 adults. In 2010–2014, the global range in age-standardized 5-year net survival for the most common sub-types was broad: in the range 20%–38% for diffuse and anaplastic astrocytoma, from 4% to 17% for glioblastoma, and between 32% and 69% for oligodendroglioma. For patients with glioblastoma, the largest gains in survival occurred between 2000–2004 and 2005–2009. These improvements were more noticeable among adults diagnosed aged 40–70 years than among younger adults. Conclusions: To the best of our knowledge, this study provides the largest account to date of global trends in population-based survival for brain tumors by histology in adults. We have highlighted remarkable gains in 5-year survival from glioblastoma since 2005, providing large-scale empirical evidence on the uptake of chemoradiation at population level. Worldwide, survival improvements have been extensive, but some countries still lag behind. Our findings may help clinicians involved in national and international tumor pathway boards to promote initiatives aimed at more extensive implementation of clinical guidelines

Techno-economic analysis of hybrid PV/T systems under different climate scenarios and energy tariffs

Producción CientíficaThis paper presents the techno-economic study of a hybrid PV/T system for the simultaneous production of electric and thermal energy under different climate scenarios and energy tariffs. A simulator was developed and validated using TRNSYS software to perform a comparative energy study of five cities with different weather conditions and energy prices: Mexicali, Soria, Bigene, Fresno and Madison. Our work proposes an extended analysis with sites that have not been studied before, and complements the scope of previous work. Under same requirements of thermal energy for DHW demand, energy production was analyzed during an entire year of operation, using different numbers of PV/T modules. Results show that the city of Mexicali is the place where most energy, both thermal and electrical, is produced. In this same locality a solar thermal fraction of 80% can be reached with only three modules installed. Energy feasibility contrasts drastically with economic benefit, where Soria presents the most attractive investment returns and monetary savings of the scenarios analyzed. Moreover, a comparison of investment returns is presented, considering subsidies in the initial investment, where return of up to 1.8 years result with a 75% subsidy. In addition, a relation of the climatic conditions of the studied cities is presented, such as solar radiation and ambient temperature, in the performance of the PV/T technologies. The conclusions of the study help decision making and planning of financial support programs, since it was considered extreme climates and representative of most of the sites where PV/T systems would be installed.Thematic Network “CIUDADES INTELIGENTES TOTALMENTE INTEGRALES, EFICIENTES Y SOSTENIBLES (CITIES)” no 518RT055

Low-temperature multiple-effect desalination/organic Rankine cycle system with a novel integration for fresh water and electrical energy production

Producción CientíficaThis paper presents a novel energetic integration of a Multiple Effect Thermal Desalination System (MED) and an Organic Rankine Cycle (ORC) for simultaneous production of potable water and electrical energy, using lowtemperature energetic sources. The thermal energy required for the system's operation is supplied by the MED's evaporator, while the ORC is activated using a fraction of the latent heat of condensation of the water vapor produced in the first effect of the MED. By doing this, the production of water in the first stage of the desalination system increases and, thus, the final production of distillate also increases. A simulation and validation of the proposal was conducted. The MED/ORC system has a 3.95% increase on the average Performance Ratio when the electrical energy production increases in 10 kW, presenting only a 1.57% increase on the total heat transfer area. MED/ORC system with an electrical energy production of 50kW is 22% more efficient in water desalination than a MED system without integration, while requiring only 6.9% more heat transfer area. The results show that the MED/ORC energetic integration studied benefits both the final production of desalinized water, and the MED's efficiency without considerably increasing the required heat transfer area.“CIUDADES INTELIGENTES TOTALMENTE INTEGRALES, EFICIENTES Y SOSTENIBLES (CITIES)” no 518RT055

Exogenous enzymes in aquaculture: Alginate and alginate-bentonite microcapsules for the intestinal delivery of shrimp proteases to Nile tilapia

Shrimp processing waste holds digestive proteases with a great potential to be used as feed supplement for Nile tilapia Oreochromis niloticus. In the present work, we characterize both sodium alginate (A) and sodium alginate-bentonite (AB) microcapsules to entrap enzymes obtained from Pleoticus muelleri processing waste. Also, we evaluate these encapsulation methods as a strategy to improve intestinal delivery of exogenous enzymes in O. niloticus in order to enhance their digestion process. The effects of different storage methods, in vitro simulation of gastric pH conditions and exposition to 40 °C were studied. In order to evaluate if microencapsulated shrimp enzymes are active when they reach fish gut, animals were exposed to three treatments: (1) fast, (2) diet and, (3) AB capsules + diet. Alginate capsules were more affected by different storage methods than alginate-bentonite ones. SEM images showed a correlation between decreased enzyme activity and capsule microstructure changes. The best method to store the AB beads is at −20 °C. After incubating for 7 h at 40 °C, we observed a notorious reduction in the enzyme activities of both microcapsules. On the other hand, at pH 3 both microcapsules prevented enzyme irreversible denaturalization and kept 100% of their activity. The overall results indicate that AB capsules are better vehicles to deliver shrimp enzymes in Nile tilapia. In the bioassay, we observed that when fish were fed with treatment 3, the alkaline protease activity in their intestines was 27% higher than that of the diet fish group. Thus, encapsulated shrimp enzymes have a great potential to be used as a feed supplement in fish nutrition. Further trials involving grow bioassays are needed to verify if this shrimp enzyme contained in AB capsules improve fish digestion, feed conversion, body weight and survival rate.Fil: Rodriguez, Yamila Eliana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mar del Plata. Instituto de Investigaciones Marinas y Costeras. Universidad Nacional de Mar del Plata. Facultad de Ciencias Exactas y Naturales. Instituto de Investigaciones Marinas y Costeras; ArgentinaFil: Laitano, Marìa Victoria. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mar del Plata. Instituto de Investigaciones Marinas y Costeras. Universidad Nacional de Mar del Plata. Facultad de Ciencias Exactas y Naturales. Instituto de Investigaciones Marinas y Costeras; ArgentinaFil: Pereira, Nair de Los Angeles. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mar del Plata. Instituto de Investigaciones Marinas y Costeras. Universidad Nacional de Mar del Plata. Facultad de Ciencias Exactas y Naturales. Instituto de Investigaciones Marinas y Costeras; ArgentinaFil: López Zavala, Alonso A.. Universidad de Sonora; MéxicoFil: Haran, Nora Selma. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mar del Plata. Instituto de Investigaciones Marinas y Costeras. Universidad Nacional de Mar del Plata. Facultad de Ciencias Exactas y Naturales. Instituto de Investigaciones Marinas y Costeras; ArgentinaFil: Fernandez Gimenez, Analia Veronica. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mar del Plata. Instituto de Investigaciones Marinas y Costeras. Universidad Nacional de Mar del Plata. Facultad de Ciencias Exactas y Naturales. Instituto de Investigaciones Marinas y Costeras; Argentin